Mylan N.V. - Strategy, SWOT and Corporate Finance Report
Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Mylan N.V. (Mylan or ‘the company’) is a leading provider of generic pharmaceutical products. It also develops, licenses, manufactures, markets and distributes branded generic and specialty pharmaceuticals. The company primarily operates in North America and Europe. It is headquartered in Canonsburg, Pennsylvania.
Detailed information on Mylan N.V. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Mylan N.V. in the form of a SWOT analysis
An in-depth view of the business model of Mylan N.V. including a breakdown and examination of key business segments
Intelligence on Mylan N.V.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Mylan N.V., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Mylan N.V. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Mylan N.V. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Mylan N.V.'s business structure, strategy and prospects.